跳至主要内容
临床试验/NCT02266342
NCT02266342已完成不适用

Evaluation on the Treatment of Diseases of the Thoracic Aorta With the Thoracic Endoprosthesis GORE® TAG®

W.L.Gore & Associates1 个研究点 分布在 1 个国家目标入组 154 人开始时间: 2014年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
154
试验地点
1
主要终点
Number of Subjects With All-cause Mortality (Long-term)

研究概览

简要总结

This is a French Registry mandated by the French National Health Authority assessing long-term (5-years) safety of the GORE® TAG® Thoracic Endoprosthesis treating diseases of the thoracic aorta.

详细描述

Endovascular therapy to treat thoracic disease seems to provide a plausible benefit compared to surgery in terms of operative mortality and severe morbidity. The French National Health Authority (HAS) requires a 5-year follow-up as part of the renewal of reimbursement for these endoprostheses in order to collect long-term follow-up data under real-life conditions of use.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient where a GORE® TAG® or Conformable GORE® TAG® Thoracic Endoprosthesis is implanted (successfully or not) for the treatment of disease of the descending thoracic aorta.
  • Patient who had previously consented to the collection and processing of personal medical data.
  • Patient older than 18 years at the time of treatment.

排除标准

  • Patients who have already received treatment with a thoracic endoprosthesis other than the GORE® TAG® or Conformable GORE® TAG® Thoracic Endoprosthesis and for whom 'revision' or reintervention is required.
  • Patients whose clinical follow-up is not possible (i.e. patients who cannot return for control visits because they live abroad).

结局指标

主要结局

Number of Subjects With All-cause Mortality (Long-term)

时间窗: 5 years

次要结局

  • Number of Subjects With Excluded Aneurysm, Penetrating Aortic Ulcer (PAU), False Lumen or Site of Rupture(5 years)
  • Number of Subjects With Cardiac, Renal, and Pulmonary Complications(5 years)
  • Number of Subjects With Device-related Complications(5 years)
  • Number of Subjects With Disease Related Mortality(5 years)
  • Number of Subjects With Neurological Complications(5 years)
  • Number of Subjects With Surgical Conversion(5 years)
  • Number of Subjects With Secondary Procedures(5 years)

研究者

发起方
W.L.Gore & Associates
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

GORE® TAG® Thoracic Endoprosthesis French Mandatory... | 临床试验